142 related articles for article (PubMed ID: 27261588)
1. Extracellular matrix protein ITGBL1 promotes ovarian cancer cell migration and adhesion through Wnt/PCP signaling and FAK/SRC pathway.
Sun L; Wang D; Li X; Zhang L; Zhang H; Zhang Y
Biomed Pharmacother; 2016 Jul; 81():145-151. PubMed ID: 27261588
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic downregulated ITGBL1 promotes non-small cell lung cancer cell invasion through Wnt/PCP signaling.
Gan X; Liu Z; Tong B; Zhou J
Tumour Biol; 2016 Feb; 37(2):1663-9. PubMed ID: 26307393
[TBL] [Abstract][Full Text] [Related]
3. Fibronectin promotes migration and invasion of ovarian cancer cells through up-regulation of FAK-PI3K/Akt pathway.
Yousif NG
Cell Biol Int; 2014 Jan; 38(1):85-91. PubMed ID: 24115647
[TBL] [Abstract][Full Text] [Related]
4. Integrin β-like 1 protein (ITGBL1) promotes cell migration by preferentially inhibiting integrin-ECM binding at the trailing edge.
Jang DG; Kwon KY; Song EK; Park TJ
Genes Genomics; 2022 Apr; 44(4):405-413. PubMed ID: 35066808
[TBL] [Abstract][Full Text] [Related]
5. ITGBL1 promotes migration, invasion and predicts a poor prognosis in colorectal cancer.
Qiu X; Feng JR; Qiu J; Liu L; Xie Y; Zhang YP; Liu J; Zhao Q
Biomed Pharmacother; 2018 Aug; 104():172-180. PubMed ID: 29772438
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of ITGBL1 predicts poor prognosis and promotes chemoresistance in ovarian cancer.
Song J; Yang P; Lu J
Cancer Biomark; 2020; 27(1):51-61. PubMed ID: 31683459
[TBL] [Abstract][Full Text] [Related]
7. Src and FAK mediate cell-matrix adhesion-dependent activation of Met during transformation of breast epithelial cells.
Hui AY; Meens JA; Schick C; Organ SL; Qiao H; Tremblay EA; Schaeffer E; Uniyal S; Chan BM; Elliott BE
J Cell Biochem; 2009 Aug; 107(6):1168-81. PubMed ID: 19533669
[TBL] [Abstract][Full Text] [Related]
8. FAK-ERK activation in cell/matrix adhesion induced by the loss of apolipoprotein E stimulates the malignant progression of ovarian cancer.
Lai H; Zhao X; Qin Y; Ding Y; Chen R; Li G; Labrie M; Ding Z; Zhou J; Hu J; Ma D; Fang Y; Gao Q
J Exp Clin Cancer Res; 2018 Feb; 37(1):32. PubMed ID: 29458390
[TBL] [Abstract][Full Text] [Related]
9. The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration.
Bian D; Mahanivong C; Yu J; Frisch SM; Pan ZK; Ye RD; Huang S
Oncogene; 2006 Apr; 25(15):2234-44. PubMed ID: 16301993
[TBL] [Abstract][Full Text] [Related]
10. Focal adhesion kinase signaling is necessary for the Cyclosporin A-enhanced migration and invasion of human trophoblast cells.
Tang CL; Zhao HB; Li MQ; Du MR; Meng YH; Li DJ
Placenta; 2012 Sep; 33(9):704-11. PubMed ID: 22766276
[TBL] [Abstract][Full Text] [Related]
11. Enterolobium contortisiliquum trypsin inhibitor (EcTI), a plant proteinase inhibitor, decreases in vitro cell adhesion and invasion by inhibition of Src protein-focal adhesion kinase (FAK) signaling pathways.
de Paula CAA; Coulson-Thomas VJ; Ferreira JG; Maza PK; Suzuki E; Nakahata AM; Nader HB; Sampaio MU; Oliva MLV
J Biol Chem; 2012 Jan; 287(1):170-182. PubMed ID: 22039045
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid induces nuclear FAK translocation and reduces breast cancer cell adhesion through Moesin, FAK, and Paxillin.
Sanchez AM; Shortrede JE; Vargas-Roig LM; Flamini MI
Mol Cell Endocrinol; 2016 Jul; 430():1-11. PubMed ID: 27130522
[TBL] [Abstract][Full Text] [Related]
13. Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
Mol Cancer; 2005 Oct; 4():37. PubMed ID: 16209712
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of integrin β1 decreases the malignancy of ovarian cancer cells and potentiates anticancer therapy via the FAK/STAT1 signaling pathway.
Zhang L; Zou W
Mol Med Rep; 2015 Dec; 12(6):7869-76. PubMed ID: 26497667
[TBL] [Abstract][Full Text] [Related]
15. Quantitative in vivo imaging of the effects of inhibiting integrin signaling via Src and FAK on cancer cell movement: effects on E-cadherin dynamics.
Canel M; Serrels A; Miller D; Timpson P; Serrels B; Frame MC; Brunton VG
Cancer Res; 2010 Nov; 70(22):9413-22. PubMed ID: 21045155
[TBL] [Abstract][Full Text] [Related]
16. Alterations in ovarian cancer cell adhesion drive taxol resistance by increasing microtubule dynamics in a FAK-dependent manner.
McGrail DJ; Khambhati NN; Qi MX; Patel KS; Ravikumar N; Brandenburg CP; Dawson MR
Sci Rep; 2015 Apr; 5():9529. PubMed ID: 25886093
[TBL] [Abstract][Full Text] [Related]
17. Recruitment of focal adhesion kinase and paxillin to beta1 integrin promotes cancer cell migration via mitogen activated protein kinase activation.
Crowe DL; Ohannessian A
BMC Cancer; 2004 May; 4():18. PubMed ID: 15132756
[TBL] [Abstract][Full Text] [Related]
18. ITGBL1 transcriptionally inhibited by JDP2 promotes the development of pancreatic cancer through the TGF-beta/Smad pathway.
Du T; Zhang K; Zhang Z; Guo A; Yu G; Xu Y
Braz J Med Biol Res; 2022; 55():e11989. PubMed ID: 35584452
[TBL] [Abstract][Full Text] [Related]
19. Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines.
Chikara S; Lindsey K; Borowicz P; Christofidou-Solomidou M; Reindl KM
BMC Complement Altern Med; 2017 Jan; 17(1):30. PubMed ID: 28068967
[TBL] [Abstract][Full Text] [Related]
20. Cell surface heat shock protein 90 modulates prostate cancer cell adhesion and invasion through the integrin-β1/focal adhesion kinase/c-Src signaling pathway.
Liu X; Yan Z; Huang L; Guo M; Zhang Z; Guo C
Oncol Rep; 2011 May; 25(5):1343-51. PubMed ID: 21369706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
